Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Survivin Urine mRNA Assay to Estimate Risk of Bladder Cancer Found on Cystoscopy

NCT00315653 is registered in ClinicalTrials.gov with Fujirebio Diagnostics, Inc. as lead sponsor.

NCT NCT00315653
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00315653 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Survivin Urine mRNA Assay to Estimate Risk of Bladder Cancer Found on Cystoscopy
Lead sponsor
Fujirebio Diagnostics, Inc.
Phase
Observational
Overall status
Completed
Start date
September 30, 2005
Completion date
November 30, 2007
Enrollment
600
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer